Back

Medscape, LLC

  • Antibodies, Bispecific
  • Lymphoma

Expanding Frontiers: Bispecific Antibodies in Marginal Zone Lymphoma

The goal of this activity is for learners to be better able to define new scientific evidence for BsAbs for MZL and how they may inform future treatment decisions.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 0.25 credits

MOC types

ABIM — Medical KnowledgeUp to 0.25 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 0.25 credits
  • MOC · Up to 0.25 points
  • Commercial Support
  • Released
    Jul 14, 2026
  • Last day to claim credit
    Jul 15, 2027 9 months left